Description
Mounjaro 12,5 mg 1 pen
Composition:
Tirzepatide 12,5 mg per dose.
Excipients: solution for injection.
Product Description:
Mounjaro is a prescription injectable solution formulated for subcutaneous use once weekly.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that improves glycemic control in adults with type 2 diabetes and supports weight management.
Indications for Use:
Improves blood sugar control in type 2 diabetes, supports weight reduction, and enhances metabolic regulation.
Method of Administration and Dosage:
Inject subcutaneously once weekly using the pre-filled Pen.
Rotate injection sites (abdomen, thigh, upper arm).
Dosage adjusted by physician.
Contraindications:
Hypersensitivity to tirzepatide or excipients.
Not indicated for type 1 diabetes or diabetic ketoacidosis.
Precautions:
Use under medical supervision.
Monitor for gastrointestinal side effects and hypoglycemia when combined with insulin or sulfonylureas.
Adverse Reactions (Side Effects):
Nausea, vomiting, diarrhea, decreased appetite, possible injection site reactions.
Pregnancy and Lactation:
Not recommended; consult physician.
Storage Conditions:
Refrigerate at 2-8 °C.
Do not freeze.
Protect from light.
Packaging:
Carton box containing 1 pre-filled pen (4 doses).
